Medication Quick Facts
📋Overview
Myfembree is a combination medication containing relugolix, estradiol, and norethindrone acetate. It works by modulating the body's hormonal signals, specifically targeting the production of estrogen in the ovaries.
The therapy utilizes a gonadotropin-releasing hormone (GnRH) receptor antagonist alongside supplemental estrogen and progestin. This combination is designed to regulate hormonal activity and maintain a stable physiological environment.
🛡️ Educational information only
This content is provided for general health education and awareness and is based on publicly available medical information. It is not intended to replace professional medical advice, diagnosis, or treatment, and should not be used to make healthcare decisions. Always seek the guidance of a qualified healthcare professional regarding any medical condition, medication, supplement, or procedure.
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
